贝叶斯式的临床试验设计,具有多个时间到事件的结果,受功能治疗的约束
Seoyoon Cho1, Matthew A Psioda2, Joseph G Ibrahim1
1Department of Biostatistics, University of North Carolina, Chapel Hill, USA.
Journal of biopharmaceutical statistics
|January 27, 2025
概括
这项研究引入了贝叶斯临床试验设计,用于分析癌症患者的生存数据,特别是对于潜在治愈的疾病. 它有助于确定在瘤学试验中准确结果所需的样本大小.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 医学瘤学 医学瘤学
背景情况:
- 先进的医学治疗需要临床试验设计,以考虑生存曲线高原,特别是在瘤学中.
- 许多癌症患者,包括患有黑色素瘤,肺癌和子宫内膜癌的患者,在诊断后可以达到正常寿命,这表明"治愈"的部分.
研究的目的:
- 开发一个贝叶斯临床试验设计方法,用于多变量时间到事件的结果,并结合化分数.
- 从贝叶斯的角度建立一个框架来确定这些试验中的样本大小.
主要方法:
- 贝叶斯的方法使用高斯的合器共同建模多变量时间到事件结果,容纳化分数.
- 使用点质量采样先验来确定足够的统计能力和I型错误控制的最小样本大小.
主要成果:
- 拟议的方法有效地模拟了多变量时间到事件数据,用修复的分数.
- 模拟研究表明,贝叶斯设计在确定适当的样本大小方面具有实用性.
结论:
- 开发的贝叶斯学方法提供了一个强大的框架,用于设计和分析在瘤学中用治愈分数进行临床试验.
- 这种方法有助于优化样本大小,确保涉及潜在治疗疾病的试验的统计学严谨性,如子宫内膜癌研究所示.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
134
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
134
Kaplan-Meier Approach
82
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
82
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Introduction To Survival Analysis
172
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
172
Assumptions of Survival Analysis
86
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
86
Censoring Survival Data
57
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
57


